IP Verse

Strawman competitive analysis

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026

Patent Number	Title	Applicant	Opposition Date
EP3783027	Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases	OSE IMMUNOTHERAPEUTICS	Sep 3, 2026
EP3672684	Electroporation Delivery Systems And Methods Of Using Electroporation Delivery Systems	CARDIAC PACEMAKERS	Sep 2, 2026
EP4025192	Process For Producing A Tablet Comprising Glp-1 Peptides	NOVO NORDISK	Sep 2, 2026
EP3449940	Antibody-Containing Preparation	CHUGAI SEIYAKU KABUSHIKI KAISHA	Aug 18, 2026
EP3310340	High Concentration Formulation	CASSIOPEA	Aug 5, 2026
EP3440518	Real Time Monitoring Of Product Purification	BOEHRINGER INGELHEIM RCV	Aug 5, 2026
EP3917493	Topical Gel Compositions Of Naproxen	BAYER HEALTHCARE	Aug 4, 2026
EP4138695	Adaptive Ecg Triggering In An Ablation System	BOSTON SCIENTIFIC	Aug 4, 2026
EP4032503	Transcatheter Atrio-Ventricular Valve Prosthesis	HIGHLIFE	Jul 29, 2026
EP3660032	Capture Purification Processes For Proteins Expressed In A Non-Mammalian System	AMGEN	Jul 21, 2026

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
STRAWMAN	471	-	-	-
AMGEN	14	163	8	11
CHUGAI SEIYAKU KABUSHIKI KAISHA	3	114	-	1
NOVARTIS	12	542	-	21